Purchase Order 75F40119P10344
- Not listed
- This is a $96,000.00 firm fixed-price purchase order contract awarded by the Medical Command (MEDCOM) of the U.S. Department of the Army to Rokabio Inc., doing business as Roka Bioscience, a for-profit, woman-owned manufacturer of medical diagnostics and analytical instruments. The contract is for the delivery of the ATLAS System, a specialized molecular detection instrument used to rapidly identify pathogens and bacteria, primarily in support of the Department of Defense's Food Analysis and...
- This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Rokabio Inc., doing business as Roka Bioscience, a for-profit woman-owned manufacturer. The one-year contract, valued at $275,725.00, is for the delivery of chemistry reagents. Rokabio provides specialized medical devices, assay kits, and related services to support Department of Defense health agencies and military medical readiness programs. Past federal contracts indicate the company has...
- This firm fixed-price purchase order was awarded by the Department of the Army Medical Command to Rokabio Inc., doing business as Roka Bioscience, a for-profit, woman-owned manufacturer of medical devices and assays. The contract, valued at $122,850.00, is for the delivery of EG2 Combo STEC Assay kits, which are used to test for dangerous E.coli strains. Rokabio has previously provided the Army and other DoD agencies with automated molecular detection instruments, assay reagents, and...
- This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Rokabio Inc., doing business as Roka Bioscience, a for-profit, woman-owned manufacturer of medical devices and assay reagents. The $160,699.00 contract funds the delivery of the company's specialized EG2 STEC assay kits and related consumables, including reagents, controls, transfer tubes, and other ancillary items, to support the Department of Defense's Food Analysis and Diagnostic Laboratory...
- <p>Rokabio Inc., doing business as Roka Bioscience, has been awarded a $195,505 firm fixed price purchase order by the Defense Health Agency to deliver the PRT-1398 EG2COMBO STEC assay. The contract has no set-aside designation and requires completion of the assay by September 30, 2023. Roka Bioscience will perform the contract from its location in Fort Sam Houston, Texas to support the Defense Health Agency's medical product needs. No major subcontractors were identified.</p>
- <p>This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Roka Bioscience, Inc., a for-profit manufacturer, for an Automated Open Platform Molecular Detection System with service maintenance. The contract has a ceiling value of $84,000.00 and was awarded on April 26, 2016, with a final completion date of May 2, 2018. The contract is set aside for small businesses.</p>
- This is a $103,210.32 firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Rokabio Inc., a woman-owned small business. The contract is for the delivery of EG2 Combo Shiga toxin-producing E. coli (STEC) assay kits and associated services to support the Department of Defense's Food Analysis and Diagnostic Laboratory (FADL) at military installations, including Fort Sam Houston and Fort Sill. This award was made under full and open competition with no set-aside...
- This firm fixed price purchase order was awarded by the Department of the Army Medical Command to Rokabio Inc., doing business as Roka Bioscience, for annual preventive maintenance. The $82,850 contract will provide preventive maintenance services at the place of performance in San Antonio, TX from October 2018 through October 2023. The original solicitation sought annual preventive maintenance as described, with the award resulting from the "Annual Preventive Maintenance" solicitation...
- This federal contract award is for molecular testing equipment, with a ceiling value of $247,811.23. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, on July 11, 2025. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price pricing type. The funding agency is the Defense Health Agency, a defense agency. The contract does not have a set-aside designation,...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $947,520.62, was awarded by the Medical Command within the U.S. Department of Defense on October 1, 2020 for a period ending on September 30, 2021. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation....
This federal contract award is for the ROKA ATLAS SYSTEM, a purchase order contract valued at $82,808.17 awarded to Rokabio Inc., a for-profit, woman-owned manufacturer of medical diagnostics and analytical laboratory instruments. The contract, which has a firm fixed price and ultimate completion date of August 16, 2024, was awarded on July 4, 2019 by the Food and Drug Administration, a civilian agency. The contract does not have a set-aside designation. Rokabio Inc., doing business as Roka Bioscience, specializes in advanced molecular detection technologies for rapid pathogen and bacterial identification, with a focus on military and healthcare applications. This contract supports the Department of Defense's Food Analysis and Diagnostic Laboratory (FADL) at various military installations, providing specialized diagnostic products and associated maintenance services to enhance military medical diagnostics capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $16.2k | 8/14/20 | |
| Not listed | Not listed | $15.8k | 7/4/19 |